Dae Hwa Pharm Non-Registered Executive Bang Sin-won Acquires 1,000 Shares via Open Market Purchase... Small Buy Signals Management Interest
Reporter: Bang Sin-won, non-registered executive (Managing Director) of Dae Hwa Pharm
Change: Increased from 6,000 to 7,000 shares (+1,000 shares), ownership ratio from 0.03% to 0.04%
Purchase method: 4 open market purchases from April 2025 to May 2026, average price 13,651 won (range: 12,800~16,460 won)
Current price comparison: Average purchase price of 13,651 won is 4.0% higher than current price of 13,120 won
Significance: Although insider buying may signal management confidence, the tiny change in stake means limited market impact
[AI Comprehensive Analysis]This small insider purchase could be interpreted as a sign of management confidence, but the increase of only 0.01 percentage point in ownership has virtually no real impact on the stock price. It is hardly a short-term positive catalyst, and other factors should be considered for investment decisions.
KOSDAQ Filing Information
Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders